Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0121 Transporter Info | ||||
| Gene Name | SLC17A8 | ||||
| Transporter Name | Vesicular glutamate transporter 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A8 gene | [1] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
|
Tissue |
Blood; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC17A8 gene, which in turn affects the expression or function of the drug transporter Vesicular glutamate transporter 3. | |||||
|
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A8 gene | [2] | ||||
|
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
|
Tissue |
Brain; Cervix; Colon; Coronary artery; Liver; Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC17A8 gene, which in turn affects the expression or function of the drug transporter Vesicular glutamate transporter 3. | |||||
|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC17A8 gene | [3] | ||||
|
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
|
Tissue |
Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC17A8 gene, which in turn affects the expression or function of the drug transporter Vesicular glutamate transporter 3. | |||||
|
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
ETV4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Activation of SLC17A8 gene in health condition | [4] | ||||
|
TF Protein Name |
ETS translocation variant 4 | Transcription Factor Info | ||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Dorsal root ganglion | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Wistar rats | |||||
|
Detailed Description |
ETS translocation variant 4 (ETV4) has been reported to activate the transcription of SLC17A8 gene in health condition, which leads to an increased expression of the drug transporter Vesicular glutamate transporter 3. | |||||
|
ETV5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Activation of SLC17A8 gene in health condition | [4] | ||||
|
TF Protein Name |
ETS translocation variant 5 | Transcription Factor Info | ||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Dorsal root ganglion | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Wistar rats | |||||
|
Detailed Description |
ETS translocation variant 5 (ETV5) has been reported to activate the transcription of SLC17A8 gene in health condition, which leads to an increased expression of the drug transporter Vesicular glutamate transporter 3. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.